Has Eugene Curry, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,110,088 in general payments to Eugene Curry, MD across 194 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Eugene Curry, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Eugene Curry, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Eugene Curry, MD

Foot and Ankle Surgery · Dallas, TXNPI 1710992110

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $2,978,700 of the $3,110,088 with a category attached, or 95.8%. Arthrex accounts for 98.5% of it on its own, with 8 other manufacturers making up the rest. Among foot and ankle surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,110,088in general payments, 2019–2025

Across 194 payments — averaging $16,031 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$3.1M
Stryker$44K
Pylant Medical$2K
Medline Industries LP$61
Amgen$48
Orthofix Medical, Inc.$36
plus $75 from 3 others

What the payments were for

Royalty or licence$2,978,70096%
Consulting fees$44,1881%
Speaking & faculty fees$74,6432%
Travel & lodging$9,1560%
Food & beverage$3,4010%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	118	$3,063,815
Stryker(2 entities)	39	$43,590
Pylant Medical	26	$2,464
Medline Industries LP	1	$61
Amgen	3	$48
Orthofix Medical, Inc.	2	$36
Ferring Pharmaceuticals Inc.	2	$36
Johnson & Johnson	2	$24
Ossur Americas, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ARTHREX$12,359,034
DISTAL EXTREMITIES IMPLANTS SOFT TISSUE ANCHORS$353,187
DISTAL EXTREMITIES IMPLANTS SOFT TISSUE PLANTAR PLATE$288,540
SHOULDER IMPLANTS BICEPS REPAIR FIBERTAK$288,340
DISTAL EXTREMITIES INSTRUMENTS DISPOSABLE KITS FIBERTAK$253,235
DISTAL EXTREMITIES IMPLANTS FOREFOOT BUNION$199,084
SHOULDER INSTRUMENTS ANCHOR SPECIFIC INSTRUMENTS BICEPS REPAIR$154,103
DISTAL EXTREMITIES INSTRUMENTS SOFT TISSUE DISPOSABLE KITS$99,952
DISTAL EXTREMITIES IMPLANTS FOREFOOT PLANTAR PLATE$65,047
DISTAL EXTREMITIES IMPLANTS TIGHTROPE SYNDESMOSIS TIGHTROPES$3,500
EZOUT$3,150
DISTAL EXTREMITIES IMPLANTS TENODESIS OTHER$1,600
STRYKER F1$900
REMB$602
1788$450

How this compares

$3,110,088 in reported general payments places this provider in the 95th percentile of 684 foot and ankle surgery providers in Texas.

See all foot and ankle surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$184,349

Medicare patients

633

Services billed

2,754

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ondansetron OdtOndansetron	86	$781
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	92	$672
Ibuprofen	30	$322
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	16	$186
Tramadol Hcl	11	$32

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Dallas

Paul KimDallas$928K
John EarlyDallas$553K
Dane WukichDallas$189K
Charles CookDallas$92K
Trapper LalliDallas$74K
Veerabhadra ReddyDallas$59K
John NoackDallas$49K
William McGarveyKaty$3.5M
Graham HamiltonEdinburg$2.1M
Mark DaltonAustin$1.9M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →